Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of varenicline on cognitive impairment in patients with schizophrenia
IRCT20101108005138N4Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of varenicline in schizophrenia, sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Change in cognitive impairment. Started Sep 2018; status: completed.
02
Drugs
varenicline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20101108005138N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101108005138N4.